Company: SPEG
Filing Date: 2025-06-20
Form Type: S-1/A
Source: 0001213900-25-055713
Chunk: 296

Company: Silver Pegasus Acquisition Corp.
Filing Date: 2025-06-20
Form: S-1/A
Chunk 296
---
 articles of association will provide that the authorized number of directors may be changed only by resolution of the board of directors. Subject to the terms of any preference shares, any or all of the directors may be removed from office at any time by an ordinary resolution, which requires the affirmative vote of at least a majority of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the company. Prior to the consummation of an initial business combination, only holders of our Class B ordinary shares will have the right to vote on the appointment and removal of directors. Our board of directors may, by a vote of a majority of our directors then in office, appoint any person to be a director, either to fill a vacancy or as an additional director. 183 Securities Eligible for Future Sale Immediately after this offering we will have 13,333,333 (or 15,333,333 if the underwriters’ over -allotmentoption is exercised in full) ordinary shares outstanding, which includes 10,000,000 public Class A ordinary shares (or 11,500,000 if the underwriters’ over -allotmentoption is exercised in full), 3,333,333 Class B ordinary shares (or 3,833,333 Class B Shares if the underwriters’ over -allotmentoption is exercised in full). Of these shares, the Class A ordinary shares sold in this offering (10,000,000 Class A ordinary shares if the underwriters’ over -allotmentoption is not exercised and 11,500,000 shares if the underwriters’ over -allotmentoption is exercised in full) will be freely tradable without restriction or further registration under the Securities Act, except for any Class A ordinary shares purchased by one of our affiliates within the meaning of Rule 144 under the Securities Act. All of the outstanding founder shares (3,333,333 founder shares if the underwriters’ over -allotmentoption is not exercised and 3,833,333 founder shares if the underwriters’ over -allotmentoption is exercised in full) and all of the outstanding private placement warrants (3,250,000 private placement warrants or 3,550,000 private placement warrants if the underwriters’ over -allotmentoption is exercised) will be restricted securities under Rule 144, in that they were issued in private transactions not involving a public offering. Rule